Doi.org/10.1074/jbc.M802840200
Revision as of 19:52, 2 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells ; Tasneem Motiwala Sarmila Majumder Kalpana Ghoshal Huban Kutay Jharna Datta Satavisha Roy David; NULL; 11/07/2008; https://doi.org/10.1074/jbc.M802840200 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target Article[edit | edit source]
PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells ; Tasneem Motiwala Sarmila Majumder Kalpana Ghoshal Huban Kutay Jharna Datta Satavisha Roy David; NULL; 11/07/2008; https://doi.org/10.1074/jbc.M802840200
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.